Our analysis, conducted in different NSCLC tumor samples and two NSCLC cell lines, indicated that PATZ1 and PD-L1 expressions are negatively associated and that PATZ1 overexpression downregulates PD-L1 expression. This evidence concerns the gene PATZ1 and neoplasm.